JAN
09
0

A piercing issue

A piercing issue

 

 

 

As dentists, we are aware that our patients are afraid of receiving anaesthetic injections. It’s the needle and the anticipation of the pain that does it – and it’s a big problem. For us, it can be a real issue. While we may be very skilled at administering anaesthetic, when faced with a nervous patient things become a little more complicated and, if the procedure goes poorly, we can be left doubting our own skills. In the case of extremely nervous patients, who we have had a great deal of difficulty injecting, we sometimes think it would just have been easy to sedate the patient from the outset. But sedation, of course, is just a short-term fix. It benefits us, as the clinician, more than the patient – it doesn’t remedy their fear.

As such, there has been a succession of different delivery systems for anaesthesia that have attempted to alleviate our patient’s fears. One of the most popular options is the anaesthetic wand. This device gives patients a much calmer and gentler injection due to its computerised delivery mechanism. It’s a great piece of kit and many dental practices have adopted it into every day procedures – mine included. I’ve actually found that my patients, who have historically been afraid of injections, have responded very positively to the wand – and have really appreciated the alternative option.

However, at the end of the day, the wand still uses a needle.

What dentists have been looking for, then, is the needleless anaesthetic – the Holy Grail of dentistry. This is why an article in the news piqued my interest recently. Apparently, a company in America has developed a completely needle-free option that consists of a simple nasal spray.

From the information we have available, this new nasal spray system looks quite promising. It induces minimal side effects (runny noses mostly) and is demonstrably effective. Unfortunately, it is only effective at numbing from one upper pre-molar to the other – and this, as we all know, is the area in which we are probably the most skilled at administering anaesthetic already.

What we need, therefore, is a system that will let us anaesthetise the lower mandibular molars – especially those with hot pulps. This is the hardest area to anaesthetise and unfortunately the nasal spray may be the wrong pharmaceutical to inhale for adequate relief.

As such, I can’t see this new system being revolutionary. I do believe that anything that helps our patients feel more at ease in the treatment room is of great value and I do not doubt that in very specific circumstances, this nasal spray will be an effective option. Patients in need of very simple restorative procedures, who are scared of the needle, will undoubtedly benefit – and this is not something to scoff at.

But for other procedures, we will simply have to rely on the tools we have available now and, for the time being, the quest for that Holy Grail must continue.

 

 

For further information please call EndoCare on 020 7224 0999

Or visit www.endocare.co.uk

 

EndoCare, led by Dr Michael Sultan, is one of the UK’s most trusted Specialist Endodontist practices. Through the use of the latest technologies and techniques, the highly-trained team can offer exceptional standards of care – always putting the patient first. What’s more, EndoCare is a dependable referral centre, to which dentists from across the country send their patients for the best in specialist endodontic treatment.

e-max.it: your social media marketing partner
  4944 Hits
4944 Hits

GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group

cogora

GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.

The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website. 

“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”

Tony will continue involvement in GDPUK on a consulting basis.

GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.

Please do not re-register if you have forgotten your details,
follow the links above to recover your password &/or username.
If you cannot access your email account, please contact us.

Mastodon Mastodon